Outcome of Board Meeting

Revenue Growth 20pctPat NegativeEbitda Margin CompressionExceptional ItemResults View source PDF

TTKHLTCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.6%1-day move

₹886.20

prior close

₹920.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.7-0.4-0.3+1.6+4.6+2.2+4.7+2.5+0.4-1.0+4.9+2.1——

Up moveDown movePending

AI summary

TTK Healthcare Ltd reported FY26 revenue of Rs. 85,728 lakhs, up 7% from Rs. 80,149 lakhs in FY25. However, profit after tax declined 19.6% to Rs. 6,568 lakhs from Rs. 8,166 lakhs, primarily due to an exceptional charge of Rs. 758 lakhs for new Labour Code implementation (gratuity and compensated absences). EBITDA margin compressed to Rs. 9,833 lakhs from Rs. 10,608 lakhs. EPS fell to Rs. 46.48 from Rs. 57.79. The auditor issued an unmodified (clean) opinion. The Board recommended a dividend of Rs. 10 per share (100%). Key appointments include reappointment of Executive Chairman T T Raghunathan for 5 years from November 2026, and Geeyes & Co. as Cost Auditor for FY27.

Likely market impact

PAT declined nearly 20% despite modest revenue growth, driven by regulatory-driven labour costs. The clean audit and dividend recommendation are positive, but margin compression and profit decline may concern investors.